TAP Spectracef Additional Bronchitis Data To Be Submitted In January
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
TAP is planning to respond to FDA’s Oct. 27 "approvable" letter for the cephalosporin antibiotic Spectracef (cefditoren pivoxil) in January and expects that approval will follow in March or April.